Elan Shareholder Vote Indicates Lack Of Faith In Management’s Decisions
This article was originally published in The Pink Sheet Daily
Executive Summary
The Irish company’s investors voted against its plans to transform the company, but have left its suitor, Royalty Pharma, with few options to continue pursuing the bid.